1 to 6 of 133 results
Leiden plays a key role in the future earning capacity of the Netherlands. With leading knowledge institutions and the Leiden Bio Science Park, the city connects science, entrepeneurship and impact, making it a strong location for international congresses
Researchers at the LUMC have tested the drug IC7Fc, which combats cardiovascular disease. The drug could be an important breakthrough and step forward in the fight against cardiovascular disease, which kills 17 million people worldwide every year.
The LUMC is collaborating with KickstartAI to develop a new AI model that assists nurses in creating wound reports. The model can generate a wound report based on photographs of the wound.
The LUMC has developed a device for babies in the NICU who experience apnoea. Apnoea is a brief interruption in breathing, which can have dangerous consequences such as brain damage.
A research group at the Leiden Institute of Biology (IBL) has developed a new antibiotic against the pathogenic intestinal bacterium Clostridioides difficile.
Eli Lilly, one of the largest pharmaceutical companies in the world, is setting up a new factory in Katwijk, close to Leiden Bio Science Park. It is estimated that the factory will create 500 jobs for the region.
